Penumbra SG&A Expenses 2014-2025 | PEN
Penumbra annual/quarterly sg&a expenses history and growth rate from 2014 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Penumbra sg&a expenses for the quarter ending March 31, 2025 were $0.153B, a 6.26% increase year-over-year.
- Penumbra sg&a expenses for the twelve months ending March 31, 2025 were $0.583B, a 10.47% increase year-over-year.
- Penumbra annual sg&a expenses for 2024 were $0.574B, a 13.33% increase from 2023.
- Penumbra annual sg&a expenses for 2023 were $0.506B, a 12.62% increase from 2022.
- Penumbra annual sg&a expenses for 2022 were $0.45B, a 18.87% increase from 2021.
| Penumbra Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $574 |
| 2023 | $506 |
| 2022 | $450 |
| 2021 | $378 |
| 2020 | $287 |
| 2019 | $273 |
| 2018 | $226 |
| 2017 | $184 |
| 2016 | $148 |
| 2015 | $102 |
| 2014 | $64 |
| 2013 | $45 |
| Penumbra Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $153 |
| 2024-12-31 | $148 |
| 2024-09-30 | $140 |
| 2024-06-30 | $142 |
| 2024-03-31 | $144 |
| 2023-12-31 | $130 |
| 2023-09-30 | $126 |
| 2023-06-30 | $127 |
| 2023-03-31 | $123 |
| 2022-12-31 | $116 |
| 2022-09-30 | $109 |
| 2022-06-30 | $115 |
| 2022-03-31 | $111 |
| 2021-12-31 | $114 |
| 2021-09-30 | $94 |
| 2021-06-30 | $91 |
| 2021-03-31 | $80 |
| 2020-12-31 | $77 |
| 2020-09-30 | $76 |
| 2020-06-30 | $60 |
| 2020-03-31 | $74 |
| 2019-12-31 | $75 |
| 2019-09-30 | $69 |
| 2019-06-30 | $68 |
| 2019-03-31 | $61 |
| 2018-12-31 | $61 |
| 2018-09-30 | $56 |
| 2018-06-30 | $55 |
| 2018-03-31 | $54 |
| 2017-12-31 | $51 |
| 2017-09-30 | $46 |
| 2017-06-30 | $44 |
| 2017-03-31 | $43 |
| 2016-12-31 | $42 |
| 2016-09-30 | $38 |
| 2016-06-30 | $36 |
| 2016-03-31 | $33 |
| 2015-12-31 | $29 |
| 2015-09-30 | $27 |
| 2015-06-30 | $26 |
| 2015-03-31 | $20 |
| 2014-12-31 | |
| 2014-09-30 | $17 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.854B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $184.618B | 80.86 |
| Thermo Fisher Scientific (TMO) | United States | $151.077B | 18.27 |
| Edwards Lifesciences (EW) | United States | $44.183B | 28.97 |
| IDEXX Laboratories (IDXX) | United States | $42.193B | 48.49 |
| Alcon (ALC) | Switzerland | $42.098B | 28.45 |
| DexCom (DXCM) | United States | $31.306B | 48.39 |
| IQVIA Holdings (IQV) | United States | $26.844B | 15.04 |
| Mettler-Toledo (MTD) | United States | $24.183B | 28.76 |
| STERIS (STE) | Ireland | $23.305B | 25.67 |
| Waters (WAT) | United States | $20.402B | 28.78 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.717B | 0.00 |
| Hologic (HOLX) | United States | $14.358B | 15.60 |
| Sysmex ADR (SSMXY) | Japan | $10.777B | 30.57 |
| Masimo (MASI) | United States | $9.115B | 33.62 |
| Globus Medical (GMED) | United States | $7.826B | 18.65 |
| Glaukos (GKOS) | United States | $5.531B | 0.00 |
| Teleflex (TFX) | United States | $5.217B | 8.61 |
| TransMedics (TMDX) | United States | $4.314B | 93.77 |
| Integer Holdings (ITGR) | United States | $4.155B | 21.77 |
| PROCEPT BioRobotics (PRCT) | United States | $3.250B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.485B | 14.80 |
| Nihon Kohden (NHNKY) | Japan | $2.265B | 25.98 |
| Veracyte (VCYT) | United States | $2.092B | 29.35 |
| Elekta AB (EKTAY) | Sweden | $1.872B | 16.83 |
| Alphatec Holdings (ATEC) | United States | $1.587B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.317B | 123.40 |
| Pulse Biosciences (PLSE) | United States | $1.042B | 0.00 |
| OPKO Health (OPK) | United States | $1.007B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.903B | 4.80 |
| IRadimed (IRMD) | United States | $0.756B | 38.38 |
| SiBone (SIBN) | United States | $0.704B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.685B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.560B | 8.71 |
| RxSight (RXST) | United States | $0.550B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.534B | 12.52 |
| OrthoPediatrics (KIDS) | United States | $0.500B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.468B | 12.46 |
| Delcath Systems (DCTH) | United States | $0.462B | 0.00 |
| AxoGen (AXGN) | United States | $0.446B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.406B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.361B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.357B | 0.00 |
| NeuroPace (NPCE) | United States | $0.347B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.318B | 0.00 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.32 |
| Neuronetics (STIM) | United States | $0.226B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.224B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.203B | 0.00 |
| Inogen (INGN) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| CVRx (CVRX) | United States | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.139B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.129B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.101B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 46.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.038B | 0.00 | |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.51 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |